Page 21 - Rna News Today

Both sides of the COVID vaccination debate are guilty of some degree of brainwashing, with critical thought being more important than ever.

Vaxess Technologies, a life sciences company developing a shelf-stable vaccine patch with potential for self-application, has announced an additional $9 million in venture capital funding, with investors including RA Capital, The Engine, and GHIC, and Ulu Ventures.

Content by MilliporeSigma. Locally, at MilliporeSigma, science starts with Bob DeMoulin and his mini but mighty team of 40 colleagues working out of the Barton Distribution Center in St. Louis,

The agency's decision on Monday sets up shots to be rolled out later this month.

RNA vaccines against Covid-19 have proven effective at reducing the severity of disease. However, a team of researchers at MIT is working on making them even better.

In its second big pharma deal to date, Shape Therapeutics Inc. drew Otsuka Pharmaceutical Co. Ltd. to the table in a potential $1.5 billion-plus collaboration initially aimed at developing gene therapies for ocular diseases. The multitarget agreement, which includes options for additional targets and tissue types, will combine Shape’s AI-driven adeno-associated virus (AAV) platform and Otsuka’s expertise in ophthalmology to develop intravitreally delivered AAV therapies.

With the rise of mRNA-based treatments, the field of oncology is about to go through a significant change.

Profund Advisors LLC acquired a new position in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 57,365 shares of the biotechnology company’s stock, valued at approximately $881,000. Other hedge funds and other institutional investors have also […]

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) shares reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $7.65 and last traded at $7.70, with a volume of 205688 shares. The stock had previously closed at $7.97. Analysts Set New Price Targets Several brokerages recently commented on […]

Largest organization of OB-GYNs in America accepted \ million from HHS to promote COVID-19 vaccines to PREGNANT WOMEN 08/30/2023 // Arsenio Toledo //